Cargando…
Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302826/ https://www.ncbi.nlm.nih.gov/pubmed/30587940 http://dx.doi.org/10.2147/PPA.S182765 |
_version_ | 1783382059722473472 |
---|---|
author | Katzmann, Julius L Mahfoud, Felix Böhm, Michael Schulz, Martin Laufs, Ulrich |
author_facet | Katzmann, Julius L Mahfoud, Felix Böhm, Michael Schulz, Martin Laufs, Ulrich |
author_sort | Katzmann, Julius L |
collection | PubMed |
description | BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP. PATIENTS AND METHODS: This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart. RESULTS: A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications. CONCLUSION: Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care. |
format | Online Article Text |
id | pubmed-6302826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-63028262018-12-26 Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk Katzmann, Julius L Mahfoud, Felix Böhm, Michael Schulz, Martin Laufs, Ulrich Patient Prefer Adherence Original Research BACKGROUND: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence. OBJECTIVE: The aim of this study was to elucidate the associations between adherence to lipid-and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP. PATIENTS AND METHODS: This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart. RESULTS: A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications. CONCLUSION: Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care. Dove Medical Press 2018-12-18 /pmc/articles/PMC6302826/ /pubmed/30587940 http://dx.doi.org/10.2147/PPA.S182765 Text en © 2019 Katzmann et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Katzmann, Julius L Mahfoud, Felix Böhm, Michael Schulz, Martin Laufs, Ulrich Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title_full | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title_fullStr | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title_full_unstemmed | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title_short | Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
title_sort | association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302826/ https://www.ncbi.nlm.nih.gov/pubmed/30587940 http://dx.doi.org/10.2147/PPA.S182765 |
work_keys_str_mv | AT katzmannjuliusl associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk AT mahfoudfelix associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk AT bohmmichael associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk AT schulzmartin associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk AT laufsulrich associationofmedicationadherenceanddepressionwiththecontroloflowdensitylipoproteincholesterolandbloodpressureinpatientsathighcardiovascularrisk |